Lexaria Bioscience Corp. — Director's Dealing 2015

Dec 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2015-03-26

Reporting Person: DOCHERTY JOHN MARTIN (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-16	Common Shares	A	55000	—	Acquired	605000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-16	Stock Options	$0.09	A	50000	Acquired	2020-03-26	Common Shares (50000)	Direct
2015-12-16	Warrants	$0.23	A	13000	Acquired	2017-05-15	Common Shares (13000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	550000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.09	2020-03-26	Common Shares (500000)	500000	Direct
Warrants	$0.23	2017-05-15	Common Shares (130000)	130000	Indirect

Footnotes

F1: Adjusted to forward 1.1 split

F2: Adjusted price to Forward 1.1 split